To investigate whether ATM inhibition can affect the EMT and metastatic potential of cisplatin-resistant NSCLC cells, we treated A549cisR and H157cisR with an ATM inhibitor CP466722. This evidence concerns the gene ATM and non-small cell lung carcinoma.